Baupost Group - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baupost Group ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$87,692,000
-9.6%
25,791,6780.0%0.67%
-20.8%
Q2 2018$96,977,000
-8.1%
25,791,6780.0%0.85%
-16.6%
Q1 2018$105,488,000
-12.0%
25,791,6780.0%1.02%
-14.2%
Q4 2017$119,931,000
-34.5%
25,791,6780.0%1.19%
-48.0%
Q3 2017$183,121,000
-1.8%
25,791,6780.0%2.28%
+7.1%
Q2 2017$186,474,000
+17.4%
25,791,6780.0%2.13%
+13.8%
Q1 2017$158,877,000
+5.1%
25,791,6780.0%1.87%
-5.1%
Q4 2016$151,139,000
+10.4%
25,791,6780.0%1.97%
+1.3%
Q3 2016$136,954,000
-19.8%
25,791,6780.0%1.95%
-16.0%
Q2 2016$170,741,000
+41.8%
25,791,6780.0%2.32%
+33.3%
Q1 2016$120,447,000
-7.5%
25,791,6780.0%1.74%
-26.4%
Q4 2015$130,248,000
+54.1%
25,791,6780.0%2.36%
+67.8%
Q3 2015$84,522,000
-67.2%
25,791,6780.0%1.41%
-67.2%
Q2 2015$257,401,000
-9.7%
25,791,678
+15.2%
4.29%
-10.4%
Q1 2015$284,900,000
+10.0%
22,380,200
+22.3%
4.79%
-5.9%
Q4 2014$258,945,000
+2.9%
18,300,0000.0%5.09%
+16.0%
Q3 2014$251,625,000
+55.2%
18,300,000
+73.6%
4.38%
+66.0%
Q2 2014$162,105,000
+50.7%
10,539,986
+67.0%
2.64%
+1.6%
Q1 2014$107,537,0006,310,8502.60%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders